Condition: Pulmonary Hypertension Due to Left Heart Disease · Sponsor: Zagazig University
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
This description comes directly from the study's public registry record.
Heba M EL-Asser, MD · 01062393152 · aseelaswad1@yahoo.com
Amany S abdelazeem, MD · 01287220016 · dola.salah2009@gmail.com
Always discuss trial participation with your own doctor first.
| Zagazig University | Zagazig, Sharqia Province, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04484675